Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
5.39
+0.19 (3.65%)
At close: Dec 5, 2025, 4:00 PM EST
5.42
+0.03 (0.46%)
After-hours: Dec 5, 2025, 7:24 PM EST
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Vanda Pharmaceuticals stock have an average target of 14, with a low estimate of 11 and a high estimate of 20. The average target predicts an increase of 159.74% from the current stock price of 5.39.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vanda Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +271.06% | Nov 19, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +104.08% | Nov 5, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $13 → $11 | Buy | Maintains | $13 → $11 | +104.08% | Oct 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +271.06% | Aug 21, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $13 | Buy | Initiates | $13 | +141.19% | May 14, 2025 |
Financial Forecast
Revenue This Year
222.64M
from 198.77M
Increased by 12.01%
Revenue Next Year
270.66M
from 222.64M
Increased by 21.57%
EPS This Year
-2.35
from -0.33
EPS Next Year
-1.57
from -2.35
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 232.5M | 304.5M | |
| Avg | 222.6M | 270.7M | |
| Low | 211.5M | 231.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 17.0% | 36.8% | |
| Avg | 12.0% | 21.6% | |
| Low | 6.4% | 4.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.86 | -0.49 | |
| Avg | -2.35 | -1.57 | |
| Low | -3.44 | -2.37 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.